description

Britain's AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in a development pipeline that now includes a possible coronavirus vaccine. Ciara Lee reports

general info

  • Uploaded    06/01/2020
  • Business & Finance
  • Musk mocks Tesla skeptics with satin shorts
  • World shares rally to 4-week highs
  • chinatimes
  • Congo and the chocolate factory
  • Boeing signals end of 747 jumbo jet - sources
  • JPMorgan drops terms 'master,' 'slave'
  • Gilead's remdesivir gets conditional EU clearance
  • Washington Redskins might change its name
  • Delivery Hero orders surge amid lockdowns